Hamburg, Germany

Barbara Freund


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Barbara Freund: Pioneering Nanoparticle Research

Introduction

Barbara Freund is a distinguished inventor based in Hamburg, Germany, who has significantly contributed to the field of nanoparticle applications in medicine. With a total of two patents to her name, she stands out for her innovative approaches to tackling autoimmune diseases and chronic inflammatory conditions.

Latest Patents

Her latest inventions focus on the development of nanoparticle compositions aimed at generating regulatory T cells. These nanoparticles are engineered for targeted delivery of antigens specifically to liver cells, including liver sinusoidal endothelial cells (LSEC) and Kupffer cells. The technology encompasses pharmaceutical compositions and methods beneficial for preventing and treating autoimmune diseases, allergies, and other chronic inflammatory conditions. The nanoparticles consist of a micelle made from an amphiphilic polymer, which enhances their water solubility, and a peptide linked to the micelle that includes at least one T cell epitope. This unique design allows for the effective in vivo generation of CD4+CD25+FOXP3+ regulatory T cells, also known as Tregs.

Career Highlights

Barbara Freund currently works at Topas Therapeutics GmbH, a company known for its cutting-edge research in therapeutic innovations. Her work is instrumental in shaping new methodologies for the treatment of complex medical conditions through advanced nanoparticle technology. Freund's contributions to the field have positioned her as an influential figure in molecular therapy and immunology.

Collaborations

Throughout her career, Barbara has collaborated closely with notable colleagues such as Jörg Heeren and Peter Nielsen. These partnerships exemplify the collaborative spirit in research environments, where diverse expertise comes together to foster innovation and address healthcare challenges.

Conclusion

With her pioneering work in the development of nanoparticle-based therapies, Barbara Freund is making a significant impact in the fight against autoimmune diseases and chronic inflammatory conditions. Her innovative spirit and dedication to advancing medical science represent the essence of what it means to be a true inventor in today’s world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…